Physiologically-based pharmacokinetic modeling of nilotinib for drug-drug interactions, pediatric patients, and pregnancy and lactation
This article is protected by copyright. All rights reserved.PMID:37909674 | DOI:10.1002/jcph.2379
Source: The Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Xiaomei I Liu Ruby Leong Gilbert J Burckart Andr é Dallmann Source Type: research
More News: Chronic Leukemia | Chronic Myeloid Leukaemia | Drugs & Pharmacology | Ketoconazole | Leukemia | Nilotinib | Pediatrics | Pregnancy | Study | Tasigna